Form D · Private Equity Fund

OrbiMed Private Investments V, LP

New York, NY · CIK 0001589316

Offering snapshot reported Nov 5, 2013 · SEC filing

Reported sold
$700M
Offering amount: $700M
Investors reported
66
Form D · investor count
Minimum accepted
$150K
Reported outside-investor minimum
First sale
Oct 31, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 5, 2013Initial$699,500,000No comparison66SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$1.74M (estimated)
Finders' fees
$0
Form D file number
021-205773

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Merrill Lynch, Pierce, Fenner & Smith Incorporated7691

Source: Form D, filed Nov 5, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED PRIVATE INVESTMENTS V, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value
$328M
Beneficial owners
462
ADV minimum commitment
$10M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP NEW YORK, New York, United States
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-7934003414

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sven H. Borho Executive
Carl L. Gordon Executive
Geoffrey C. Hsu Executive
Samuel D. Isaly Executive
W. Carter Neild Executive
N/A N/A Orbi Med Advisors Llc Executive
N/A N/A Orbi Med Capital Gp V Llc Executive
Michael B. Sheffery Executive
Jonathan T. Silverstein Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Orbimed Advisors Llc 601 Lexington Avenue, 54 Th Floor
New York, NY, 10022